A fixed, low dose of anti-CD20 antibody (Rituximab) is an effective treatment for patients with chronic immune thrombocytopenia

被引：0
|
作者：
El-Najjar, I [1 ]
Rule, SAJ [1 ]
Nokes, TJC [1 ]
机构：
[1] Derriford Hosp, Dept Haematol, Plymouth PL6 8DH, Devon, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2006年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [21] Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus
    Lee, J-W
    Kim, H-A
    Sung, J-M
    Suh, C-H
    LUPUS, 2010, 19 (02) : 227 - 228
  • [22] Rituximab (anti-cd20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment
    Emilia Parodi
    Bruno Nobili
    Silverio Perrotta
    Sofia Maria Rosaria Matarese
    Giovanna Russo
    Maria Licciardello
    Marco Zecca
    Franco Locatelli
    Simone Cesaro
    Gianni Bisogno
    Paola Giordano
    Domenico De Mattia
    Ugo Ramenghi
    International Journal of Hematology, 2006, 84 : 48 - 53
  • [23] Retreatment of 11 patients with immune thrombocytopenic purpura with the anti-CD20 monoclonal antibody, rituximab.
    Cooper, N
    Stasi, R
    Michel, M
    Bussel, JB
    BLOOD, 2003, 102 (11) : 86B - 86B
  • [24] Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
    Cooper, HL
    Healy, E
    Theaker, JM
    Friedmann, PS
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (04) : 366 - 368
  • [25] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
    Stasi, R
    Pagano, A
    Stipa, E
    Amadori, S
    BLOOD, 2001, 98 (04) : 952 - 957
  • [26] Anti-cd20 monoclonal antibody treatment (rituximab) in acute lymphoblastic leukemia
    Jándula, BM
    Nomdedeu, J
    Marín, P
    Muñoz, L
    Vivancos, P
    BONE MARROW TRANSPLANTATION, 2001, 27 : S92 - S92
  • [27] Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)
    Dupuy, A
    Viguier, M
    Bédane, C
    Cordoliani, F
    Blaise, S
    Aucouturier, F
    Bonnetblanc, JM
    Morel, P
    Dubertret, L
    Bachelez, H
    ARCHIVES OF DERMATOLOGY, 2004, 140 (01) : 91 - 96
  • [28] Treatment of Cutaneous Lymphoid Hyperplasia with the Monoclonal Anti-CD20 Antibody Rituximab
    Martin, Stephanie J.
    Duvic, Madeleine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (03): : 286 - 288
  • [29] Successful treatment of refractory Evan syndrome with anti-CD20 antibody (rituximab)
    Recht, M
    PEDIATRIC RESEARCH, 2003, 53 (04) : 299A - 299A
  • [30] Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-cd20 monoclonal antibody
    Ahmed, S
    Singh, A
    Krauss, J
    Wentz, T
    Gunaratnam, NT
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 408 - 410
12345